Taiwan · Delayed Price · Currency is TWD Shine-On BioMedical Statistics
Total Valuation
TPEX:6926 has a market cap or net worth of TWD 3.46 billion. The enterprise value is 2.51 billion.
| Market Cap | 3.46B |
| Enterprise Value | 2.51B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6926 has 49.80 million shares outstanding.
| Current Share Class | 49.80M |
| Shares Outstanding | 49.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.55% |
| Owned by Institutions (%) | n/a |
| Float | 22.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.56 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.41 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -19.07 |
Financial Position
The company has a current ratio of 115.08, with a Debt / Equity ratio of 0.00.
| Current Ratio | 115.08 |
| Quick Ratio | 113.25 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -3,811.57 |
Financial Efficiency
Return on equity (ROE) is -11.35% and return on invested capital (ROIC) is -8.06%.
| Return on Equity (ROE) | -11.35% |
| Return on Assets (ROA) | -7.96% |
| Return on Invested Capital (ROIC) | -8.06% |
| Return on Capital Employed (ROCE) | -13.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -5.32M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -65,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.11% in the last 52 weeks. The beta is -0.02, so TPEX:6926's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | +3.11% |
| 50-Day Moving Average | 72.83 |
| 200-Day Moving Average | 67.69 |
| Relative Strength Index (RSI) | 34.72 |
| Average Volume (20 Days) | 36,760 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -133.41M |
| Pretax Income | -117.14M |
| Net Income | -117.07M |
| EBITDA | -133.02M |
| EBIT | -133.41M |
| Earnings Per Share (EPS) | -2.36 |
Balance Sheet
The company has 956.63 million in cash and 1.98 million in debt, giving a net cash position of 954.65 million or 19.17 per share.
| Cash & Cash Equivalents | 956.63M |
| Total Debt | 1.98M |
| Net Cash | 954.65M |
| Net Cash Per Share | 19.17 |
| Equity (Book Value) | 972.93M |
| Book Value Per Share | 19.54 |
| Working Capital | 964.77M |
Cash Flow
In the last 12 months, operating cash flow was -131.32 million and capital expenditures -142,000, giving a free cash flow of -131.46 million.
| Operating Cash Flow | -131.32M |
| Capital Expenditures | -142,000 |
| Free Cash Flow | -131.46M |
| FCF Per Share | -2.64 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6926 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.38% |
| FCF Yield | -3.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |